Biology Reference
In-Depth Information
References
Almeida GD, Porada CD, St Jeor S, Ascensao JL (1994) Human cytomegalovirus alters
interleukin-6 production by endothelial cells. Blood 83:370-376
Almeida-Porada G, Porada CD, Shanley JD, Ascensao JL (1997) Altered production of GM-CSF
and IL-8 in cytomegalovirus-infected, IL-1- primed umbilical cord endothelial cells. Exp
Hematol 25:1278-1285
Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N (2003) Angiogenesis assays: a critical
overview. Clin Chem 49:32-40
Billingham ME (1992) Histopathology of graft coronary disease. J Heart Lung Transplant 11:S38-S44
Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA (2006) A review on pro- and
anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53:89-103
Bruning JH, Persoons MCJ, Lemstrom KB, Stals FS, De Clereq E, Bruggeman CA (1994)
Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented
by antiviral therapy in the form of HPMPC. Transplant Int 7:365-370
Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A (1999) Intercellular adhe-
sion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate
early proteins. Transplantation 67:137-144
Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660
Charrier L, Yan Y, Driss A, Laboisse CL, Sitaraman SV, Merlin D (2005) ADAM-15 inhibits
wound healing in human intestinal epithelial cell monolayers. Am J Physiol Gastrointest Liver
Physiol 288:G346-G353
Clinton SK, Libby P (1992) Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med
116:1292
Deotero J, Gavalda J, Murio E, et al (1998) Cytomegalovirus disease as a risk factor for graft loss
and death after orthotopic liver transplantation. Clin Invest Dis 26:865-870
Ely JM, Greiner DL, Lubaroff DM, Fitch FW (1983) Characterization of monoclonal antibodies
that define rat T cell alloantigens. J Immunol 130:2798
Fitzgerald JT, Gallay B, Taranto SE, McVicar JP, Troppmann C, Chen X, McIntosh MJ, Perez RV
(2004) Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated
with decreased renal allograft and patient survival. Transplantation 77:1405-1411
Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3:643-651
Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989)
Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.
JAMA 261:3561-3566
Guidolin D, Vacca A, Nussdorfer GG, Ribatti D (2004) A new image analysis method based on
topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the
matrigel assay in vitro. Microvasc Res 67:117-124
Helantera I, Loginov R, Koskinen P, Tornroth T, Gronhagen-Riska C, Lautenschlager I (2005)
Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1,
PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrol Dial
Transplant 20:790-796
Helantera I, Teppo AM, Koskinen P, Tornroth T, Gronhagen-Riska C, Lautenschlager I (2006)
Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients
during cytomegalovirus infection. Transpl Immunol 15:217-221
Hosenpud JD, Shipley GD, Wagner CR (1992) Cardiac allograft vasculopathy: current concepts,
recent developments and future directions. J Heart Lung Transplant 11:9-23
Humar A, St Louis P, Mazzulli T, McGeer A, Lipton J, Messner H, MacDonald KS (1999)
Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone
marrow transplant recipients. J Infect Dis 179:484-488
Inkinen K, Holma K, Soots A, Krogerus L, Loginov R, Bruggeman C, Ahonen J, Lautenschlager
I (2003) Expression of TGF-beta and PDGF-AA antigens and corresponding mRNAs in
cytomegalovirus-infected rat kidney allografts. Transplant Proc 35:804-805
